05 - ASCO again...
Jun 21, 2024 ·
4m 57s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Altri importanti lavori presentati all’ASCO 2024 sono stati contemporaneamente pubblicati sul Journal of Clinical Oncology. In rete possiamo trovare anche tutti gli abstracts di ASCO 2024 e il “prezioso” ASCO...
show more
Altri importanti lavori presentati all’ASCO 2024 sono stati contemporaneamente pubblicati sul Journal of Clinical Oncology. In rete possiamo trovare anche tutti gli abstracts di ASCO 2024 e il “prezioso” ASCO Educational Book.
Riferimenti bibliografici
show less
Riferimenti bibliografici
- Abstracts ASCO 2024
- ASCO Educational Book
- Solomon BJ, et al. Lorlatinib Versus Crizotinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study. J Clin Oncol 2024: JCO2400581. doi: 10.1200/JCO.24.00581. Epub ahead of print.
- Paz-Ares LG, et al. Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study. J Clin Oncol 2024: JCO2400733. doi: 10.1200/JCO.24.00733. Epub ahead of print.
Information
| Author | ACCMED |
| Organization | ACCMED |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
